CAPSTONE INVESTMENT ADVISORS, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 22 filers reported holding NOVOCURE LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2024$4,816,875
+5.7%
5,250,0000.0%0.02%
+21.4%
Q4 2023$4,557,525
-27.6%
5,250,000
-27.6%
0.01%
-50.0%
Q3 2023$6,298,800
-59.2%
7,250,000
-59.2%
0.03%
-63.2%
Q2 2023$15,442,987
-28.2%
17,750,000
-28.3%
0.08%
-30.3%
Q1 2023$21,519,892
+34.7%
24,750,000
+38.2%
0.11%
-6.0%
Q4 2022$15,972,145
-13.4%
17,908,000
-12.3%
0.12%
+4.5%
Q3 2022$18,449,000
+4.4%
20,408,0000.0%0.11%
+29.1%
Q2 2022$17,663,000
-5.1%
20,408,0000.0%0.09%
+68.6%
Q1 2022$18,622,000
+104.6%
20,408,000
+106.0%
0.05%
+240.0%
Q4 2021$9,103,0009,908,0000.02%
Other shareholders
NOVOCURE LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Opti Capital Management, LP 71,346,000$61,5224.43%
BRAIDWELL LP 135,834,000$118,012,5793.73%
STEELHEAD PARTNERS LLC 41,000,000$35,287,8802.07%
DeepCurrents Investment Group LLC 45,000,000$38,726,9991.68%
TENOR CAPITAL MANAGEMENT Co., L.P. 85,445,000$73,696,3101.58%
SHENKMAN CAPITAL MANAGEMENT INC 7,066,000$6,138,9410.46%
LINDEN ADVISORS LP 42,025,000$36,154,2220.37%
Context Capital Management, LLC 2,989$2,5750.21%
Verition Fund Management LLC 18,003$15,641,0060.18%
Kohlberg Kravis Roberts & Co. L.P. 3,037,000$2,638,5460.09%
View complete list of NOVOCURE LTD shareholders